Infectious diseases
The infectious disease landscape is ever-changing with outbreaks, mutations,
emerging pathogens, and growing resistances placing pressures on healthcare
systems. Roche is determined to provide relief and care.
Infectious diseases caused by viral and bacterial pathogens
Challenge sae
represent an ever-growing medical need for millions of patients
worldwide. Combining a rich legacy in infectious diseases with theFocus
latest science and technology platforms, Roche focuses on the
discovery and development of novel treatments to address some of
the world’s most pressing health challenges.
Infectious diseases are becoming increasingly difficult to manage.
While much healthcare effort is devoted to preventing the spread
of disease and associated treatments, less attention is paid to the
impact these infections have on the broader healthcare landscape
Currently, Roche infectious diseases research and development is
dedicated to finding effective treatment for a number of life-
threatening infections that include viral hep:
drug resistant bacteria, as well as COVID-19 and HIV/AIDs. These
diseases, for which there is often a high unmet medical need,
, influenza, multi-
affect millions of people worldwide in wide degrees of severity. For
this reason, and to ensure each patient receives the most
appropriate and effective care, Roche has adopted different
strategies to tackle the spread of these infectious diseases - from
focusing efforts against multi-drug resistant bacteria into
developing treatments for the the top three Gram-negative
bacteria identified by the World Health Organization as number
one Priority Pathogens, to continuing to innovate treatment
solutions to prevent as well as treat influenza, or combining
therapies that pair direct-acting antivirals with immune-enhancing
molecules to treat viral hepatitis.
Diagnosing infectious
diseasesStories of
Infectious diseases
Without diagnostics, medicine is
blind
July 21, 2022
Roche is committed to meeting the needs of
patients, developing best-in-class diagnostic
solutions to help alleviate the global burden of
infectious diseases.
Read more
Seeallstories >
dl
COVID-19: Global partnership for a
global health emergency
May 11, 2022Overcoming barriers to equitable
HIV testing
May 11, 2022More focus areas View all focus areas >
M..~ el
Cardiometabolic diseases > Diabetes >
1/3 >
Downloads Learn more about influenza z
PDF
Discover more Innovation
Partnering 5
At Roche Partnering, we are passionate about
science: yours and ours. Through partnerships,
we hope that together we can build a better
future with medicines that make a real difference
to patients.Innovation
Clinical trials >
Clinical trials are essential to determine whether
new drugs or diagnostics are safe and effective
when used to diagnose of treat people.